Aaron Freidin Sells 1,816 Shares of Grail, Inc. (NASDAQ:GRAL) Stock

Grail, Inc. (NASDAQ:GRAL) CFO Aaron Freidin sold 1,816 shares of the firm’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $56,659.20. Following the sale, the chief financial officer now directly owns 335,170 shares in the company, valued at $10,457,304. This trade represents a 0.54 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Grail Stock Up 1.0 %

GRAL opened at $30.85 on Thursday. Grail, Inc. has a 52 week low of $12.33 and a 52 week high of $63.99. The business’s 50 day moving average is $31.42 and its two-hundred day moving average is $21.15.

Grail (NASDAQ:GRAL) last announced its earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, beating analysts’ consensus estimates of ($4.41) by $2.55. The business had revenue of $38.25 million during the quarter, compared to analyst estimates of $35.33 million. Sell-side analysts forecast that Grail, Inc. will post -15.15 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Alpha Wealth Funds LLC acquired a new stake in shares of Grail during the fourth quarter worth $2,562,000. Ameriflex Group Inc. purchased a new position in Grail during the 4th quarter worth $95,000. PVG Asset Management Corp acquired a new stake in shares of Grail in the 4th quarter worth $398,000. Public Employees Retirement System of Ohio acquired a new stake in shares of Grail in the 4th quarter worth $334,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in shares of Grail in the fourth quarter valued at about $1,201,000.

Analysts Set New Price Targets

A number of analysts have weighed in on GRAL shares. Morgan Stanley initiated coverage on shares of Grail in a report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 price objective on the stock. Wolfe Research began coverage on shares of Grail in a research report on Friday, November 15th. They issued a “peer perform” rating for the company.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.